Scott T. Reents
CIK: 0001937048
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AbbVie Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Feb 27, 2026ABBV
AbbVie Inc.
Tax Payment(F)Direct21.6K shares at avg. $232.08$5.0M - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct25.1K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct7.3K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct7.6K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct8.9K shares- - Mar 14, 2025ABBV
AbbVie Inc.
Sale(S)Direct17.6K shares at avg. $212.34$3.7M - Feb 28, 2025ABBV
AbbVie Inc.
Tax Payment(F)Direct11K shares at avg. $205.02$2.2M - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct7.6K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct8.9K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct2.4K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct5.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 27, 2026 | ABBV AbbVie Inc. | Tax Payment(F) | 21,638 | $232.08 | $5,021,747 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 25,062 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 7,260 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 7,606 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 8,910 | - | $0 | Direct |
| Mar 14, 2025 | ABBV AbbVie Inc. | Sale(S) | 17,644 | $212.34 | $3,746,527 | Direct |
| Feb 28, 2025 | ABBV AbbVie Inc. | Tax Payment(F) | 10,973 | $205.02 | $2,249,684 | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 7,608 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 8,912 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 2,398 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 5,845 | - | - | Direct |
1-11 of 11 transactions
About Reents Scott T
Reents Scott T (SEC CIK 0001937048) files insider reports with the SEC as EVP, CHIEF FINANCIAL OFFICER of AbbVie Inc. (ABBV).
Signal8 holds 5 ownership filings by Reents Scott T, all Form 4s, filed between Feb 18, 2025 and Mar 3, 2026. Those filings report 11 transactions, from Feb 13, 2025 to Feb 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Reents Scott T's filings is in NORTH CHICAGO, IL.
Recent filings by Reents Scott T
- Feb 27, 2026: Tax withholding of ABBV shares (Form 4, code F).
- Feb 18, 2026: Grants or awards of ABBV shares (4 lines, Form 4, code A).
- Mar 14, 2025: Open-market sale of ABBV shares (Form 4, code S).
- Feb 28, 2025: Tax withholding of ABBV shares (Form 4, code F).
- Feb 13, 2025: Grants or awards of ABBV shares (4 lines, Form 4, code A).
Other insiders filing for AbbVie Inc. (ABBV)
- Carethers John, Director
- Quaggin Susan E, Director
- RAPP EDWARD J, Director
- Donoghoe Nicholas, EVP, CHIEF BUS/STRAT OFFICER
- FALK THOMAS J, Director
- WADDELL FREDERICK H, Director